Uncontrollable Gastrointestinal Bleed Leads to Xarelto Lawsuit

At the same time that Cheryl Butler was seeking treatment for a deep venous thrombosis and saddle pulmonary artery embolism, Janssen Pharmaceuticals and Bayer Healthcare were engaging in an aggressive marketing campaign to promote the superiority of blood-thinner Xarelto over warfarin. Butler, who experienced a severe gastrointestinal bleed just months after beginning Xarelto, was left permanently injured. Butler has filed a lawsuit against the pharmaceutical companies joining hundreds of similar plaintiffs who have experienced life-altering bleeding side effects cause by the use of Xarelto.

Real Time Analytics